Oyster Point Pharma, Inc. SC 13D and SC 13D/A reports

Location
202 Carnegie Center, Suite 106, Princeton, NJ
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
7/19/2024, 10:38 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Jan 13, 2023
SC 13D/A Report NEW ENTERPRISE ASSOCIATES 14, L.P. -- OYSTER POINT PHARMA, INC. 13D/A(#2E) Jan 9, 2023
SC 13D/A Report SC 13D/A Jan 5, 2023
SC 13D/A Report SC 13D/A Dec 21, 2022
SC 13D/A Report NEW ENTERPRISE ASSOCIATES 14, L.P. -- OYSTER POINT PHARMA, INC. 13D/A(#1) Nov 21, 2022
SC 13D/A Report SC 13D/A Jan 13, 2022
SC 13D/A Report SC 13D/A Oct 27, 2021
SC 13D/A Report SC 13D/A May 24, 2021
SC 13D/A Report SC 13D/A Apr 5, 2021
SC 13D/A Report SC 13D/A Mar 1, 2021
SC 13D Report SC 13D Nov 14, 2019
SC 13D Report SC 13D Nov 14, 2019
SC 13D Report NEW ENTERPRISE ASSOCIATES 14, L.P. - OYSTER POINT PHARMA, INC. 13D Nov 8, 2019